Treatment with the antiviral drug remdesivir does not speed recovery from COVID-19 compared with placebo in hospitalized patients who are critically ill, according to the first randomized trial of its kind involving 237 adults from 10 hospitals in Wuhan, China.
from Latest Science News -- ScienceDaily https://ift.tt/2yaINPy
via IFTTT
Wednesday, April 29, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment